Christine Ocampo, See Remarks at Novus Therapeutics, Inc. (NVUS), bought 20,020 shares at $9.99 ($200K) on 2017-05-10, disclosed to the SEC on 2017-05-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.99 | 10,010 | $100K | 50.0% |
| 2 | $9.99 | 10,010 | $100K | 50.0% |
| Total | $9.99 avg | 20,020 | $200K | 100% |
| Filing → |
| AVNR | SELL | 2014-09-17 | $520K | — | Filing → |
| AVNR | SELL | 2014-08-28 | $13K | — | Filing → |
| AVNR | SELL | 2014-05-16 | $189K | — | Filing → |